FDA clears algorithm to reduce ECG noise on ambulatory monitoring
Click Here to Manage Email Alerts
Key takeaways:
- Algorithms to improve ECG interpretability received FDA clearance.
- The solution is designed to reduce noise contamination for ambulatory ECG monitoring.
B-Secur announced the FDA clearance and launch of its ECG algorithms and analytics designed to enhance signal clarity by reducing noise, improving ECG interpretability.
The algorithms (HeartKey Rhythm) are designed to improve the quality of ambulatory ECG monitoring and provide indicators of signal quality for health care providers, according to a company press release.
According to the release, approximately 42% of health care professionals say remote ECG readings require additional testing to confirm results and 53% say they are difficult to interpret.
“There is an ever-increasing reliance on ECG data collected outside of a controlled clinical environment,” Adrian Condon, chief technology officer and co-founder of B-Secur, said in the release. “HeartKey Rhythm significantly improves the ECG signal processing and rhythm recognition of ambulatory devices and platforms.”
Collapse
Click Here to Manage Email Alerts